23
2020
-
09
Improving the level of public health prevention and control is crucial for the application of molecular diagnostic technology
In order to alleviate the above public health burden, infection prevention and control are crucial. Molecular diagnostic technology is an effective means of early disease screening and risk prediction, as well as a weapon for disease identification and classification, personalized and precise medication. The WHO Strategy points out that using affordable and universal testing platforms that can simultaneously diagnose multiple pathogens, as well as low-cost rapid diagnostic and testing tools, has important value in early detection, prevention, and control of infections and related epidemics, helping to promote universal health coverage and healthcare for all.
Author:
In order to alleviate the above public health burden, infection prevention and control are crucial. Molecular diagnostic technology is an effective means of early disease screening and risk prediction, as well as a weapon for disease identification and classification, personalized and precise medication. The WHO Strategy points out that using affordable and universal testing platforms that can simultaneously diagnose multiple pathogens, as well as low-cost rapid diagnostic and testing tools, has important value in early detection, prevention, and control of infections and related epidemics, helping to promote universal health coverage and healthcare for all.
The lack of accurate and accessible molecular diagnostic technology has become a major obstacle to public health capacity building in many underdeveloped areas. Due to the surge in demand for nucleic acid detection during the COVID-19 epidemic, the development and application of molecular diagnostic technology in China has grown rapidly. According to the report of the National Health Commission, as of May 11, 2022, a total of 13000 medical and health institutions and 153000 technicians across the country have provided COVID-19 nucleic acid detection services, with a total detection capacity of nearly 57 million tubes per day. Such a vast nucleic acid testing capability is a valuable asset for China's society and healthcare system. How to leverage and utilize the existing nucleic acid testing capabilities is also a key concern for China's healthcare system.
key word:
Related news
No. 7, Lane 1300,Xiechun Road,Anting Town,Jiading District, Shanghai
201804
Room 905,No. 158,Minde Road,Jing'an District,Shanghai
021-36525701
Follow us
Copyright © Shanghai Gaozhuan Medical Supplies Co., Ltd All right reserved 沪ICP备2022022950号-1 SEO